ESG News For Molecular Insight Pharmaceuticals, Inc.

Greenhouse gas emissions intensity lowered by 16% and plastic footprint down 9.6% vs. 2020Commitment to ambitious climate goals: Net-zero by 2050, Scope 1 and 2 emissions down 42% by 2030Widening access to healthcare in high-burden, low-resource countries: making 100 million QuantiFERON tests for tuberculosis available in more than 130 countriesComprehensive Compliance Program: more than 7,000 employee online training modules completed

Joins “Business Ambition for 1.5˚C” campaign of the Science-Based Targets initiativeCommitment to achieve by 2030 at least 40% reduction in Scope 1 and 2 emissions, and at least 10% reduction in Scope 3 emissions, on way to reach net-zero carbon emissions by 2050